Therefore, the value of Ki-67 as a proliferation marker to discriminate the clinical behavior (benign versus malignant) of theses tumors and the influence of PDGFR-β for tumor proliferation should be evaluated in larger series. Here, PDGFRB is linked to neoplasm.